Daniel Christian Mahnert-Lueg

iCeutica, Inc. manufactures pharmaceutical products. It offers SoluMatrix platform, a drug reformulation and delivery technology for poorly water-soluble compounds. This technology enables iCeutica to make significantly improved formulations of approved and development stage drugs, some of which have been shown in late stage clinical trials to work faster, at a lower dose or be delivered to the body by an alternative route. The company was founded by James Williams and Matthew Callahan in 2005 and is headquartered in Philadelphia, PA.

UBS Wealth Management (Singapore) (UBSWM-Singapore) is the wealth management operation of UBS AG (Singapore), a subsidiary of UBS AG (NYSE: UBS) in Switzerland. The firm provides a range of services including strategic wealth planning, liquidity solutions, retirement planning and succession planning to private clients.

Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington.

Minomic International Ltd. develops diagnostic and imaging products for prostate cancer and diabetes. Its MiCheck test detects a protein that is present on cancer cells by using blood sample. The company was founded in 1974 and is headquartered in Sydney, Australia.

Biocomm Square Pty Ltd. provides business development and licensing consulting services. The firm provides business development and licensing, corporate strategy, business planning, project management and portfolio review and technology assessment services. It also offers services like market analysis, competitive intelligence, scientific and commercial evaluation and assessment, in and out licensing strategy development, arrangement and implementation, research collaboration and alliances, biotechnology, biopharmaceuticals and cellular therapeutics services. The company was founded by Andrew John Hubert Gearing and Tsutomu Mori in 2007 and is headquartered in Clayton, Australia.

Hatchtech Pty Ltd. operates as pharmaceutical product company. It offers Xeglyze lotion that is head lice treatment. The company was founded by Vernon Morrison Bowles in 2001 and is headquartered in in Melbourne, Australia.

AusBiotech Ltd. operates as an Australian biotechnology membership company. The private company is based in Melbourne, Australia. and has subsidiaries in Australia. The company was founded by Liz Dallimore. Lorraine Chiroiu has been the CEO of the company since 2008.

Part of AgResearch Ltd., Celentis Ltd. is a life science research and New Zealander development company. The company is based in Hamilton, New Zealand.

Nexvet Australia Pty Ltd. operates as a global clinical-stage biopharmaceutical company that develops and distributes medicines for companion animals. The firm focuses on transforming the therapeutic market by developing and commercializing novel biologic therapies, including products derived from its PETization technology. PETization is designed to rapidly create monoclonal antibodies that are recognized as “self” by a patient’s immune system. The company was founded by Mark Heffernan, Christopher Nigel Brown and David Gearing in February 2010 and is headquartered in Melbourne, Australia.

BioScience Managers Pty Ltd (Bioscience Managers) is a private equity & venture capital firm founded in 2003 by Jeremy Curnock Cook. The firm is headquartered in Melbourne, Australia.

Part of Firefly Health, Inc., Firefly Health Pty Ltd. is an Australian healthcare company that provides resources and tips for healthcare providers who treat Firefly Health members. The company is based in South Melbourne, Australia. The company aims to make the healthcare process easier for providers and lower healthcare costs for employees. The company was founded in 2012 and the CEO is Fay Rotenberg.

Botanix Pharmaceuticals, Inc. develops therapeutics for the treatment of serious skin diseases. Its products include BTX1503-Acne, BTX1308-Plaque Psoriasis, and BTX1204-Atopic Dermatitis. The company is headquartered in Plymouth Meeting, PA.

Part of VBI Vaccines, Inc., VBI Vaccines (Delaware), Inc. develops biopharmaceuticals. Jeffrey R. Baxter has been the CEO of the American company since 2014.

Verband Beratender Ingenieure VBI is a consulting and engineering association based in Germany.

Proniras Corp. operates as a bio technology company. The company is headquartered in Seattle, WA.

Hibercell, Inc. specializes on tumor dormancy detection and therapeutics. It provides treatment for primary tumors, metastatic cancer. The company was founded by Alan Rigby, Julio Aguirre-Ghiso, and Ari Nowacek and is headquartered in New York, NY.

JBR Pharma, Inc. operates as a virtual pharmaceutical company. The company is headquartered in Plymouth Meeting, PA.

Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA.

Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning.

Skylark Bio, Inc. operates as a biotechnology company. The company is based in Cambridge, MA.

hC Bioscience, Inc. is a biotech company based in Cambridge, MA and has subsidiaries in the United States. A single trna therapy has the potential to treat many diseases, regardless of the gene or location of the mutation. hC Bioscience is dedicated to improving the lives of patients by developing first-in-class trna-based therapeutics that target protein dysfunction. The company's innovative approach to precision protein editing has the potential to treat genetically defined conditions that account for 10-15% of all human diseases. The lead platform in development is directed at restoring protein function in diseases caused by nonsense mutations or premature termination codons (PTCs). The company was founded in 2021 by Leslie J. Williams, who has been the CEO since then.

TFC Therapeutics, Inc. is a biotech company based in New York, NY. TFC Therapeutics is developing novel biologics to target and eliminate key drivers of cancer recurrence and metastasis. The company is blending early-stage research with innovative platform design to develop next-generation treatments to eliminate the most resilient cancers and put an end to their recurrence before it begins. The company was founded in 2022 and Jennifer Power has been the CEO of the company since 2023.

SonoThera, Inc. is a biotechnology company founded by Michael H. Davidson, Kenneth P. Greenberg, and Steve Feinstein. The company is based in South San Francisco, CA. The company is dedicated to treating the root cause of human disease through genetic therapy. SonoThera is developing an ultrasound-guided, nonviral gene therapy platform and treatments designed to provide patients with the next generation of safe and effective genetic medicines. The platform utilizes sonoporation, a microbubble-mediated biophysical process to non-invasively deliver genetic payloads selectively targeting a wide range of organs within the body. Kenneth P. Greenberg has been the CEO since incorporation.